Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Share capital and reserves (Details Narrative)

v3.22.1
Share capital and reserves (Details Narrative)
 12 Months Ended
Oct. 15, 2021
CAD ($)
Feb. 28, 2021
Feb. 09, 2021
CAD ($)
Feb. 09, 2021
Feb. 28, 2020
CAD ($)
Dec. 31, 2021
CAD ($)
shares
Dec. 31, 2021
CAD ($)
$ / shares
shares
Dec. 31, 2020
CAD ($)
Dec. 31, 2019
CAD ($)
IfrsStatementLineItems [Line Items]                  
Average Remaining contractual life           4 years 1 month 9 days      
Warrants issued           $ 2,855,983      
[custom:ExpectedLife] 1 year 1 year 5 years     5 years   5 years  
Expected volatility           100.00%      
Share-based payment expense           $ 499,158   $ 293,443 $ 26,317
expected life           5 years      
exercise price warrant | $ / shares             $ 4.77    
Warrant reserve [member]                  
IfrsStatementLineItems [Line Items]                  
Average Remaining contractual life           4 years 6 months 21 days   1 month 27 days  
Warrant Outstanding [Member]                  
IfrsStatementLineItems [Line Items]                  
Warrants issued $ 371,251   $ 150,000   $ 11,066        
Expected volatility 100.00%     100.00% 99.76%        
Stock Options [Member]                  
IfrsStatementLineItems [Line Items]                  
Average Remaining contractual life           3 years 5 months 1 day   3 years 7 months 21 days  
Private Placement Warrant [Member]                  
IfrsStatementLineItems [Line Items]                  
Warrants issued           $ 7,425,000      
Number of warrants issued | shares           2,085,687 2,085,687    
Fair value of the warrants           $ 5,358,000      
Derivative warrant liability reclassified to share capital on exercise of warrants           $ 425,900      
Derivative Warrant Liabilities [Member]                  
IfrsStatementLineItems [Line Items]                  
Expected volatility           100.00%      
Share price on date of grant | $ / shares             $ 3.64    
exercise price warrant | $ / shares             $ 2.05    
Risk free rate           1.50%      
Expected dividend yield           0.00%      
Derivative Warrant Liabilitie [Member]                  
IfrsStatementLineItems [Line Items]                  
Statutory reserve           $ 4,460,000 $ 4,460,000